rfhg_103949.1

Basic information about the TSS

---

TSS ID: rfhg_103949.1 Species: human Chr: chr8		Start: 17935625 End: 17935625 Strand: +
Source datasets	EPD
Protocol	TSS_database
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: CU674224:-14 AB587340:-14 GeneID: 5108 HGNC/MGI_ID: HGNC:8727 UniProt_ID: Nearer transcript ids and distances: LF372135:-21 MA607712:-21 view more...

Gene_name: pericentriolar material 1 Gene_symbol: PCM1 Gene_synonyms: PTC4 Gene_source: HGNC:8727

TATA-Box annotation

---

Distance to TSS:	12637
Nearest PromoterID:	NM_001352653
Entrez ID:	5108
Nearest Unigene:	Hs.491148
Nearest Refseq:	NM_006197
Nearest Ensembl:	ENSG00000078674
Gene Name:	pericentriolar material 1
Gene Alias:	PTC4|RET/PCM-1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PCM1 p2@PCM1 p3@PCM1 p4@PCM1 p5@PCM1
Sample		p1@PCM1	p2@PCM1	p3@PCM1	p4@PCM1	p5@PCM1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	45.58	0.39	0.19	0.78	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	44.71	2.23	0.61	2.02	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	54.40	1.54	0.39	2.70	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	37.84	0.83	0.42	1.46	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	43.64	2.70	0.45	1.35	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	46.13	1.36	0.19	1.36	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	61.66	1.31	0.44	2.83	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	49.17	0.97	0.48	0.73	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	41.89	0.85	0.43	1.28	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	70.13	1.74	0.58	3.48	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	53.36	2.43	1.62	2.43	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	71.55	2.03	0.81	0.81	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	32.24	0.81	1.77	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	32.17	1.20	2.10	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	33.37	0.44	2.42	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	24.90	2.01	2.77	1.51	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	25.55	1.53	2.18	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.31	1.69	2.11	0.84	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	27.72	0.53	2.13	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	24.97	1.50	2.41	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	28.60	0.94	1.74	0.67	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	34.01	2.59	1.21	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	27.14	0.78	1.81	0.65	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	21.60	1.70	1.21	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	27.86	1.55	1.03	0.52	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	31.65	0.95	1.27	0.63	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	24.73	1.10	1.65	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	33.71	0.47	1.89	1.65	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	21.32	1.29	1.13	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	24.79	1.09	1.09	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	15.91	1.26	1.05	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	22.27	0.59	0.78	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	20.26	1.69	1.06	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	33.65	1.98	2.14	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.56	1.12	0.56	0.93	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	22.23	1.34	0.96	0.77	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	23.71	1.43	1.64	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.14	1.41	0.60	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	26.74	0.81	1.89	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	27.37	1.68	0.96	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	18.35	1.41	0.71	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	26.20	0.88	1.46	0.59	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	17.72	0.84	1.48	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	19.58	1.05	1.57	0.35	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	31.12	2.01	1.41	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.26	1.86	1.16	0.93	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.95	0.72	0.96	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	28.61	0.30	2.38	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.50	1.44	0.96	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	18.80	2.22	1.42	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.73	1.23	2.25	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	22.24	0.67	1.33	0.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	629.65	41.98	27.98	41.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.84	2.13	1.06	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	16.24	0.99	1.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	104.87	4.19	5.87	6.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	25.72	3.21	1.38	0.92	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	13.61	0.65	0.97	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	12.53	1.93	0.96	0.64	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.12	1.57	1.26	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	10.58	2.12	2.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	8.97	0.00	1.12	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	60.51	1.59	9.55	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	25.48	1.02	2.04	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.67	0.97	3.57	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.16	2.48	3.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	242.46	32.33	32.33	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	371.18	7.90	31.59	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	9.75	0.49	1.95	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.41	0.50	3.97	1.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	0.94	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	18.55	0.66	0.66	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.75	0.93	1.24	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	13.45	3.06	0.92	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	12.83	3.17	2.38	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	8.98	4.17	1.44	1.60	0.16
Adipocyte - omental, donor1	11473-119C6	17.94	3.82	1.91	0.25	0.00
Adipocyte - omental, donor2	11474-119C7	5.98	0.75	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	7.03	2.34	1.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	5.10	3.19	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	9.03	2.26	1.81	0.00	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	7.99	1.22	1.39	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	30.31	4.30	2.74	0.20	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	24.97	2.32	2.06	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	22.86	5.02	2.79	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	32.33	6.47	3.53	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	24.61	6.68	2.09	0.24	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	28.73	4.20	1.61	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	17.60	2.67	4.27	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	21.14	3.34	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	5.41	1.66	1.66	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	12.06	4.52	1.26	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	4.25	0.65	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	9.74	3.96	3.65	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	3.31	0.88	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.72	1.79	0.72	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	8.10	1.26	1.80	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	1.67	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	5.14	0.62	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	41.08	2.17	2.98	0.46	0.57
Anulus Pulposus Cell, donor2	11463-119B5	21.80	2.45	0.49	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	18.42	1.80	3.15	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.50	1.74	0.87	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	0.00	0.00	4.28	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	17.34	2.09	0.90	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	1.26	0.00	5.06	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.90	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.77	0.65	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	0.97	1.94	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.75	1.78	1.78	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	14.69	3.01	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	12.34	1.45	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	0.00	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.81	1.65	0.49	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	12.28	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	10.71	1.21	1.36	0.30	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	15.54	0.54	0.54	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.41	1.32	1.13	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	10.42	1.34	1.87	0.80	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	0.98	0.98	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.28	0.50	0.83	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	12.01	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	12.86	1.37	0.69	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	1.46	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.25	1.14	0.76	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	13.33	0.00	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.97	1.14	1.71	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.61	1.07	0.43	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.81	1.29	1.03	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	14.55	0.94	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.65	1.61	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	6.42	0.00	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	13.45	2.34	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	11.14	0.90	0.90	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	8.32	0.00	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	10.17	1.02	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.01	2.04	0.76	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.90	0.00	2.54	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.93	2.59	1.29	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.68	1.06	0.42	0.21	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.99	0.87	0.29	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	10.51	2.37	1.02	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.08	1.72	0.43	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	1.20	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	9.48	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.48	0.92	2.76	0.69	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	12.71	0.25	0.76	0.51	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	16.52	0.62	1.24	0.83	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	12.55	0.31	1.84	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	15.77	0.48	1.91	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.53	0.89	0.22	0.89	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	12.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	10.52	0.55	1.11	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.56	1.59	0.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.54	2.54	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.83	0.86	0.37	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	5.82	0.34	0.34	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	4.40	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	83.31	1.05	1.39	1.05	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	71.50	0.81	1.78	1.46	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	70.55	1.04	0.89	1.34	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	91.17	6.42	5.85	2.87	1.61
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	90.33	4.89	5.01	1.63	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	92.29	7.62	5.12	2.62	0.68
Basophils, donor1	12241-129G9	20.92	3.40	1.05	2.35	0.26
Basophils, donor2	12242-129H1	91.28	16.96	10.46	22.37	0.72
Basophils, donor3	12243-129H2	24.40	5.14	2.79	2.20	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	2.16	1.72	0.65	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	0.46	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	3.77	0.63	0.63	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	2.29	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	3.91	1.15	0.92	0.00	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	12.06	1.80	1.62	0.54	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	94.91	4.53	3.50	0.72	2.68
Burkitt's lymphoma cell line:RAJI	10476-106I8	74.76	1.63	1.16	1.16	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	133.99	3.20	3.52	1.92	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	196.50	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	47.90	8.45	7.89	2.82	0.56
CD14+ Monocytes, donor2	11305-117B9	45.29	8.91	6.87	4.27	0.19
CD14+ Monocytes, donor3	11381-118B4	44.79	4.83	6.37	3.29	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	67.36	24.06	7.36	0.57	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	79.61	18.20	7.96	1.52	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	67.72	26.63	10.19	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	14.31	10.70	5.49	1.01	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	17.20	6.03	5.13	0.91	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	25.58	10.90	9.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	12.89	6.19	3.68	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	14.08	9.66	2.48	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.84	11.65	3.72	0.99	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.34	7.24	3.13	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.71	8.01	2.85	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	25.90	11.97	6.09	1.09	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	19.43	6.32	3.98	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	22.18	5.81	7.39	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	29.95	9.98	6.66	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	13.54	7.59	4.02	1.34	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	10.18	9.38	4.39	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	19.57	11.87	4.79	0.83	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	11.44	5.72	5.26	0.92	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	23.30	8.14	3.85	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	19.20	9.17	2.18	0.44	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	12.10	8.88	3.23	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.18	6.63	2.62	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.46	10.94	5.05	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.63	5.70	3.86	0.73	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	14.80	5.64	3.52	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.48	7.46	3.51	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	17.96	6.28	4.88	0.70	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	15.24	7.43	2.97	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	38.37	14.66	5.60	1.08	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.43	5.73	2.05	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	15.07	6.26	4.17	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	21.34	8.35	4.18	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	23.10	9.59	3.71	1.96	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	21.02	6.70	5.31	0.46	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	22.09	6.50	3.90	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	24.92	14.48	7.32	0.62	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	19.56	12.92	6.99	0.70	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	45.49	28.32	12.71	1.11	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	24.24	11.48	4.59	1.28	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	23.27	7.68	4.83	0.44	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	22.95	9.05	5.47	0.63	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	95.52	4.06	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	88.14	8.14	14.24	1.36	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	94.24	4.14	7.25	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	104.48	5.33	6.93	0.53	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	111.50	11.79	11.26	3.22	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	102.48	11.23	4.91	1.40	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	85.49	8.63	9.41	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	105.46	5.27	9.23	2.64	1.32
CD19+ B Cells, donor1	11544-120B5	117.53	4.93	8.22	3.29	0.82
CD19+ B Cells, donor2	11624-122B4	130.58	10.88	6.53	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	114.09	7.07	7.57	4.54	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	101.01	67.88	9.70	3.64	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	67.11	41.95	4.39	0.80	0.80
CD34+ Progenitors, donor1	11545-120B6	135.55	1.00	3.01	7.03	1.00
CD34+ Progenitors, donor2	11625-122B5	128.09	1.12	5.62	7.30	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	104.08	1.88	3.01	1.13	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	143.86	2.71	4.28	0.90	1.13
CD4+ T Cells, donor1	11225-116C1	237.80	24.99	14.28	5.00	0.71
CD4+ T Cells, donor2	11306-117C1	168.40	17.15	13.47	16.53	1.22
CD4+ T Cells, donor3	11382-118B5	122.91	12.20	14.03	14.94	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	58.19	17.36	10.46	0.77	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	51.66	12.58	8.09	0.45	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	60.94	11.50	9.77	1.44	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	129.90	10.90	14.22	0.95	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	106.75	12.64	9.83	2.11	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	95.59	3.30	19.78	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	43.79	14.16	9.39	1.45	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	24.57	7.63	6.27	1.02	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.44	8.54	4.35	2.10	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	84.28	8.97	9.41	4.93	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	80.01	12.58	6.64	2.80	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	107.80	18.48	10.12	4.40	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	59.45	21.50	13.07	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	29.30	8.73	6.86	1.45	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	23.72	7.68	6.68	1.34	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	140.32	16.32	16.86	1.09	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	161.86	20.37	15.54	2.68	1.07
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	104.01	21.52	8.97	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	60.45	19.84	10.94	2.23	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	40.51	11.48	8.01	1.08	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	46.86	9.88	5.25	1.47	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	95.56	14.66	10.62	7.08	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	105.71	10.83	10.40	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	178.68	20.92	19.18	3.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	121.74	14.35	15.84	1.48	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	119.09	15.69	9.23	2.77	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	115.85	18.15	15.35	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	180.28	20.49	20.77	1.38	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	209.56	23.07	19.88	1.96	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	126.28	16.94	13.86	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	121.76	13.61	15.04	1.07	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	124.65	19.39	9.69	2.77	0.00
CD8+ T Cells, donor1	11226-116C2	204.62	13.10	11.79	34.38	0.00
CD8+ T Cells, donor2	11307-117C2	137.78	13.14	7.88	20.27	1.13
CD8+ T Cells, donor3	11383-118B6	189.62	10.60	8.33	21.71	1.01
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	26.15	2.52	1.15	2.06	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	28.52	0.72	1.20	3.83	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	34.20	0.00	1.09	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	26.72	1.20	0.90	1.80	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.68	0.72	0.72	1.92	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	26.38	0.23	0.91	2.05	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	37.81	0.87	0.87	1.30	0.65
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	32.64	0.53	1.58	2.63	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	38.23	0.94	0.47	1.41	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	41.96	0.60	0.60	3.02	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	44.16	2.03	0.29	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	41.56	0.53	0.00	1.07	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	35.90	1.75	1.31	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	37.80	0.91	0.46	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.02	0.75	0.75	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	26.29	0.72	0.36	1.44	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	30.79	0.58	0.58	2.30	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	32.76	0.94	0.24	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	39.61	0.63	1.27	2.22	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	38.75	2.77	0.92	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	37.83	0.32	2.89	0.64	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	29.45	1.15	1.15	1.91	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	38.62	0.79	0.79	1.18	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	30.26	0.76	3.03	3.03	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	70.66	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	58.05	2.80	1.40	2.80	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	63.11	1.00	1.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	36.55	0.00	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	13.83	0.49	2.47	0.49	0.99
Cardiac Myocyte, donor3	11686-122I3	18.94	0.84	1.16	0.11	0.42
Chondrocyte - de diff, donor1	11261-116G1	36.40	3.47	2.43	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	12.08	2.13	1.42	0.00	0.36
Chondrocyte - de diff, donor3	11410-118E6	16.50	2.16	3.53	0.34	0.23
Chondrocyte - re diff, donor2	11339-117F7	17.91	4.48	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	13.75	1.62	2.02	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	109.48	2.52	2.87	0.80	1.26
Ciliary Epithelial Cells, donor2	11323-117D9	42.97	1.50	1.50	1.71	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	51.42	0.80	1.59	1.06	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	103.71	4.22	4.22	0.55	7.61
Corneal Epithelial Cells, donor1	11526-119I5	2.20	1.10	0.66	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	2.28	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.79	1.28	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	225.52	12.88	2.81	3.47	4.29
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	222.36	8.83	3.47	2.84	3.15
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	113.87	3.45	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	105.72	7.13	3.02	2.92	1.94
Dendritic Cells - plasmacytoid, donor1	11228-116C4	215.23	3.76	1.71	8.88	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	175.62	3.26	1.31	7.83	2.61
Dendritic Cells - plasmacytoid, donor3	11385-118B8	230.36	2.42	0.00	14.03	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	15.51	1.67	0.17	0.00	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	0.00	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	10.18	1.13	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	13.76	0.79	0.39	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	8.73	0.29	0.29	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	27.06	1.41	0.24	0.71	0.00
Endothelial Cells - Artery, donor3	11413-118E9	9.82	1.05	0.70	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	48.54	2.44	2.44	0.00	1.77
Endothelial Cells - Lymphatic, donor2	11317-117D3	54.46	5.17	1.52	0.61	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	48.77	6.77	2.54	0.56	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	8.32	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	10.93	0.52	2.08	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	7.51	0.00	0.14	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	35.61	3.60	1.20	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	7.86	0.00	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	96.29	5.59	5.09	0.75	1.86
Endothelial Cells - Umbilical vein, donor2	11324-117E1	78.87	4.78	5.00	0.87	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	63.14	5.01	4.15	0.37	0.61
Endothelial Cells - Vein, donor1	11267-116G7	18.20	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	14.67	0.00	2.79	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	22.14	0.79	0.79	0.63	0.31
Eosinophils, donor1	12244-129H3	121.98	60.99	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	77.56	13.20	6.60	3.30	0.00
Eosinophils, donor3	12246-129H5	39.24	10.70	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.22	0.49	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	20.94	1.23	2.87	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.07	1.20	0.66	0.44	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	11.16	1.84	1.08	0.98	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	28.50	3.40	3.15	0.85	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	29.34	7.92	3.68	0.27	1.09
Fibroblast - Aortic Adventitial, donor2	11326-117E3	15.82	2.11	1.58	0.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	33.73	2.11	2.11	0.26	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	27.57	2.33	2.33	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	10.43	0.91	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	8.34	1.52	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	7.89	0.47	1.26	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	47.59	4.85	3.03	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	32.61	2.28	2.41	0.76	0.38
Fibroblast - Cardiac, donor6	11460-119B2	29.26	1.82	1.36	0.76	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.94	0.67	0.94	0.00	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.43	0.86	1.29	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	20.51	0.00	1.46	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	19.60	0.46	1.38	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	51.39	3.05	3.73	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	12.91	0.94	2.35	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	8.96	0.94	0.00	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	12.09	1.33	0.97	0.24	0.48
Fibroblast - Dermal, donor4	11450-119A1	26.34	2.49	1.36	1.47	0.68
Fibroblast - Dermal, donor5	11454-119A5	38.55	2.09	1.05	0.35	1.40
Fibroblast - Dermal, donor6	11458-119A9	32.16	1.30	2.27	0.32	0.81
Fibroblast - Gingival, donor1	11237-116D4	36.86	4.58	3.54	0.42	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	41.92	2.88	3.67	1.31	1.57
Fibroblast - Gingival, donor2	11318-117D4	30.84	2.90	2.37	0.53	0.26
Fibroblast - Gingival, donor3	11394-118C8	43.61	6.19	5.41	0.87	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	35.32	4.16	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	22.55	0.53	1.06	1.59	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	42.72	2.96	2.81	1.09	1.40
Fibroblast - Gingival, donor6 (control)	11922-125H5	38.00	2.30	2.43	0.95	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	10.94	0.71	0.71	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	33.05	1.90	1.46	0.58	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	45.00	1.91	3.27	0.55	0.95
Fibroblast - Gingival, donor8 (control)	11926-125H9	56.49	2.30	2.19	0.77	0.77
Fibroblast - Gingival, donor9 (control)	11927-125I1	51.80	0.88	1.47	0.73	0.59
Fibroblast - Lung, donor1	11270-116H1	6.80	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	31.34	4.48	7.46	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	23.00	1.06	0.63	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	2.50	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	0.00	1.40	2.80	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	12.18	1.22	0.41	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	54.89	2.52	1.94	0.78	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	57.79	3.94	1.67	1.52	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	59.36	5.20	5.51	0.00	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.90	1.14	0.76	0.00	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	18.09	1.08	2.70	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	23.66	1.97	2.67	0.12	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.35	1.77	1.11	0.33	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	6.10	0.61	0.61	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	3.34	0.00	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	0.00	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	44.65	3.57	2.78	0.99	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	25.75	2.84	2.31	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	25.42	2.56	2.17	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.08	3.01	2.41	0.30	2.11
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	41.45	3.35	2.70	0.43	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	26.07	3.04	3.29	0.25	1.27
Fibroblast - skin normal, donor1	11553-120C5	16.41	3.94	2.95	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	60.35	6.02	3.21	0.20	1.00
Fibroblast - skin normal, donor2	11561-120D4	25.92	3.62	2.61	0.60	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	43.22	4.23	2.12	0.30	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	31.81	3.15	4.47	0.33	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	43.59	3.42	2.74	0.68	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	24.30	2.96	2.96	0.00	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	28.02	5.54	2.34	0.96	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	17.71	1.35	1.52	0.67	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	14.58	2.20	3.29	0.78	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	8.72	7.84	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	15.43	6.93	3.29	0.00	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.34	6.25	2.08	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	21.97	10.99	2.56	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	35.22	0.00	0.77	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	37.01	0.64	1.91	1.91	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	80.16	3.42	2.57	1.71	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	109.48	0.28	0.55	2.48	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	99.55	0.00	1.60	0.91	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	62.01	2.18	2.58	0.79	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	98.33	0.53	0.00	1.32	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	118.72	0.65	1.63	1.96	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	59.26	1.33	1.77	2.21	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	47.91	1.27	1.98	1.13	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	57.63	1.35	1.48	1.23	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	43.25	0.81	2.69	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	38.53	0.62	0.37	0.99	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	35.99	1.11	1.25	0.69	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	29.07	1.22	0.61	0.41	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	33.54	0.68	0.46	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	40.11	1.12	1.62	1.25	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.01	1.97	2.19	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	45.21	0.30	0.89	0.59	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	49.44	2.07	1.11	1.75	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	33.51	1.79	1.12	0.45	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	47.18	0.60	0.60	0.40	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	60.39	1.19	0.68	0.51	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	80.25	2.75	2.39	0.44	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	76.90	1.25	0.42	0.31	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	60.97	0.51	0.85	0.34	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	56.32	1.55	0.77	0.55	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	66.22	1.58	0.58	0.25	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	67.38	2.45	1.63	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	45.80	0.83	0.62	1.03	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	50.50	0.81	0.92	0.46	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	49.70	1.00	1.00	1.67	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	33.95	0.44	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	43.05	0.74	0.86	0.86	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	47.17	1.13	0.81	0.81	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	41.05	0.64	0.64	1.28	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.92	0.38	0.38	0.66	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	30.84	0.79	0.47	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	40.75	1.22	0.30	1.22	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.02	1.05	0.73	0.31	0.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	34.69	0.44	1.98	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	32.26	1.12	1.12	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	43.05	0.83	0.65	0.46	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	24.60	1.07	0.27	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	29.99	0.61	1.07	1.38	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	26.56	0.91	0.52	0.26	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.02	0.81	0.54	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.71	0.74	0.37	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	30.05	1.54	0.44	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	64.46	0.00	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.53	0.92	1.32	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.81	2.02	0.40	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	70.15	2.03	1.52	0.00	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	82.61	3.78	2.59	0.80	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	48.84	1.39	3.08	1.08	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	72.63	2.05	3.89	1.02	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	39.74	0.94	2.19	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	29.95	0.57	1.13	0.85	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	74.25	2.31	1.38	1.38	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	0.00	2.47	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	68.47	2.71	2.71	1.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	59.37	1.60	1.60	3.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	92.16	3.48	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	52.40	2.60	3.25	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	73.30	1.24	4.53	1.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	89.97	0.00	3.33	19.99	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	66.00	1.40	1.40	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	52.62	0.98	2.29	1.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	69.62	0.00	1.68	8.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	67.11	1.91	0.32	0.32	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	48.57	0.68	1.02	1.02	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	64.73	0.00	0.00	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	53.83	0.57	0.00	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.75	0.89	1.18	1.78	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	83.01	3.39	1.69	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	73.73	2.07	1.66	2.49	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	70.88	1.38	1.38	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	57.66	0.77	2.31	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	48.90	0.98	0.65	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	48.16	0.67	1.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	68.96	1.54	1.93	2.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	65.39	1.03	0.34	1.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	62.12	2.48	0.00	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	70.78	1.42	0.94	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	46.47	1.21	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	77.83	0.51	1.02	1.02	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	74.18	1.99	2.39	3.19	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	69.56	1.48	1.48	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	89.71	0.00	1.18	4.72	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	49.59	0.58	1.17	1.17	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	46.08	2.19	0.44	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	73.75	2.54	0.00	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	34.62	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	47.55	0.97	1.94	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	1.14	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.81	1.66	2.08	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	4.50	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	15.54	1.90	1.90	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	8.77	1.67	2.51	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	13.93	2.67	1.74	1.04	0.70
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.87	3.21	2.19	0.51	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	17.75	4.55	2.50	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	13.88	4.15	1.75	0.55	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	11.39	3.22	1.29	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	13.99	3.23	2.58	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	11.21	2.74	1.49	0.62	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	10.64	2.57	1.37	0.51	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	13.46	1.60	2.24	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	6.16	0.00	0.00	0.56	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.90	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	10.58	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.59	0.35	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	21.51	0.87	0.87	0.52	0.70
Hepatocyte, donor1	11523-119I2	46.00	21.79	6.05	6.05	0.00
Hepatocyte, donor2	11603-120I1	38.78	31.24	8.62	0.00	0.00
Hepatocyte, donor3	11684-122I1	65.04	32.52	7.36	2.45	1.84
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	223.22	2.61	1.96	4.57	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	37.23	8.74	5.42	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	20.44	1.10	0.82	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	15.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	9.75	0.00	1.62	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	2.65	1.32	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	0.00	2.22	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	5.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	9.45	1.89	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	9.04	1.29	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	3.26	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	6.72	2.10	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	0.80	1.61	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	9.23	0.00	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	6.14	0.47	1.42	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	3.63	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	9.69	1.08	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	3.81	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	2.55	0.64	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	3.57	2.86	0.71	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.86	1.54	0.31	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	7.02	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	3.48	2.09	2.78	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	4.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	5.23	2.62	0.87	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	10.45	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	10.67	3.20	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	1.06	2.11	3.17	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	10.93	4.08	1.96	0.00	0.16
Keratinocyte - epidermal, donor2	11349-117G8	1.17	0.59	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	14.86	3.41	1.42	0.47	0.09
Keratinocyte - oral, donor1	11251-116E9	37.35	2.95	3.41	0.79	0.68
Keratocytes, donor1	11527-119I6	18.22	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	8.20	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	37.74	3.36	2.37	0.79	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	50.55	17.58	13.19	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	59.86	0.92	1.61	0.00	0.58
Lens Epithelial Cells, donor3	11690-122I7	41.88	1.31	1.31	0.20	0.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	16.96	1.42	0.83	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	8.65	0.56	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	30.38	1.89	1.73	1.26	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	13.44	0.00	1.61	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.30	1.58	0.95	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	6.90	0.32	0.22	0.22	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.16	2.46	0.00	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	3.03	0.51	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	9.43	0.42	0.56	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	15.03	0.40	1.19	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	15.51	0.78	0.58	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	3.33	0.00	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	18.47	1.74	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	9.54	0.72	0.24	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	6.04	0.41	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	15.71	0.00	0.62	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	7.17	1.87	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	8.23	0.55	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	15.14	1.65	2.30	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	5.86	0.59	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	4.73	0.00	0.25	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	27.64	1.45	1.94	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	13.20	1.35	0.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	10.29	0.45	0.30	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.89	1.04	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.24	1.05	0.00	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	7.37	0.90	0.15	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	1.38	0.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	9.78	1.32	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	5.73	0.53	0.42	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	21.81	1.45	0.48	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	12.24	0.66	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	4.21	0.25	0.25	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	36.65	1.11	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	10.38	0.49	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.05	0.41	0.41	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	19.62	0.96	0.96	0.64	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	26.78	1.22	0.91	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.70	0.56	0.98	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.40	0.71	0.71	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	5.33	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	3.73	0.00	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	10.74	0.00	0.72	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	7.19	0.33	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	3.53	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	14.23	1.49	0.99	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	7.68	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	6.86	0.00	0.90	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	20.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	4.60	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	1.48	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	7.62	1.69	0.85	0.00	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.11	1.41	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	3.74	0.93	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.18	0.52	0.52	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	3.57	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.92	1.36	0.90	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	10.76	1.45	1.16	0.87	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.80	0.90	1.80	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	9.48	0.68	0.81	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	8.73	1.03	1.03	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	12.70	0.71	1.06	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	12.66	0.67	0.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	8.15	1.53	1.02	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	12.27	1.33	0.53	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.79	1.13	1.51	0.57	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	0.00	0.00	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	7.34	1.63	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.29	1.67	2.29	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.69	0.56	1.12	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	3.09	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	12.19	2.90	1.74	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	10.46	1.20	1.20	0.60	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	13.83	1.11	2.21	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	12.37	0.71	1.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.28	0.37	1.11	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	6.91	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.06	1.54	0.38	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.93	0.57	1.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	7.38	0.82	2.46	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.33	1.36	0.90	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	8.62	0.00	2.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	10.46	0.75	2.99	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.80	2.23	1.11	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	11.63	0.86	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.14	0.00	2.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.66	0.00	1.00	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	9.05	1.21	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.82	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.19	0.69	0.69	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	8.05	1.61	0.54	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.04	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.59	0.74	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	12.79	1.16	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	15.21	0.80	1.20	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	10.18	1.45	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.96	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	6.91	0.49	1.48	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	1.88	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.53	1.01	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.66	1.35	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	7.57	0.89	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.60	0.39	1.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	7.26	0.66	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	12.97	2.08	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	8.75	0.88	1.31	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.71	0.56	2.24	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.04	1.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.03	0.39	1.54	0.77	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	9.62	1.01	1.01	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.57	0.48	0.96	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.94	1.99	1.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	5.47	1.82	1.82	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	8.99	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.36	0.38	0.76	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	8.26	1.55	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	0.60	1.21	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	11.09	1.27	1.58	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	9.06	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	4.02	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.71	1.54	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	3.40	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.32	1.25	0.83	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	5.48	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.43	0.42	0.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	9.76	0.93	0.93	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.95	0.53	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	8.08	0.81	0.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	9.18	0.92	1.84	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	6.22	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	7.41	1.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.90	0.00	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	4.92	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	6.68	0.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	10.92	0.52	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.96	2.65	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	8.31	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	66.32	14.81	3.65	0.46	0.91
Macrophage - monocyte derived, donor2	11313-117C8	26.98	3.67	1.65	0.18	0.73
Macrophage - monocyte derived, donor3	11389-118C3	39.46	7.34	2.23	0.92	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.09	4.78	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	18.38	8.87	2.85	0.79	0.16
Mallassez-derived cells, donor3	11930-125I4	16.96	3.89	2.08	0.56	0.14
Mammary Epithelial Cell, donor1	11273-116H4	42.35	4.48	3.79	0.20	0.90
Mammary Epithelial Cell, donor2	11350-117G9	22.58	5.79	1.74	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	4.99	0.50	0.75	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	202.03	6.10	6.78	45.42	0.68
Mast cell, donor1	11563-120D6	89.11	3.24	1.95	8.00	0.54
Mast cell, donor2	11565-120D8	212.78	5.65	3.57	2.67	0.89
Mast cell, donor3	11566-120D9	224.90	9.23	7.20	1.13	0.45
Mast cell, donor4	11567-120E1	236.15	7.80	6.91	1.42	2.30
Mast cell, expanded and stimulated, donor5	11940-126A5	95.15	5.66	4.21	6.76	1.55
Mast cell, expanded and stimulated, donor8	11942-126A7	54.87	2.92	2.33	23.35	0.58
Mast cell, expanded, donor5	11939-126A4	73.08	4.36	3.10	1.61	0.69
Mast cell, expanded, donor8	11941-126A6	108.12	6.36	1.67	5.52	0.50
Melanocyte - dark, donor1	11502-119F8	23.48	1.99	1.69	0.10	0.20
Melanocyte - dark, donor2	11582-120F7	12.81	2.08	1.38	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	40.42	1.74	1.01	0.43	0.36
Melanocyte - light, donor1	11274-116H5	5.64	2.12	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	6.14	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	20.30	2.29	0.52	0.21	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	32.00	1.34	1.08	0.54	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	28.66	4.82	2.41	1.34	0.00
Meningeal Cells, donor1	11493-119E8	16.00	1.74	0.87	0.00	0.12
Meningeal Cells, donor2	11573-120E7	9.68	0.88	0.44	0.88	0.00
Meningeal Cells, donor3	11654-122E7	47.84	2.36	2.45	0.82	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	29.94	2.28	1.43	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	27.67	4.23	2.92	0.50	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	15.79	0.72	0.00	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	21.39	1.91	1.69	0.64	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	13.07	1.01	3.02	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	9.23	0.00	0.44	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	0.73	1.46	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	4.50	0.20	0.41	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	30.47	2.22	1.25	0.14	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.35	0.74	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	28.68	2.89	2.89	0.39	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.45	0.30	0.89	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	5.76	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	20.20	2.13	0.35	0.00	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	21.89	2.81	3.13	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	16.69	0.73	0.00	0.00	2.18
Mesothelial Cells, donor1	11247-116E5	11.67	5.04	2.65	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	6.51	3.50	2.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	9.76	2.96	1.52	0.29	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	128.28	8.10	2.70	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	45.31	6.65	3.94	1.48	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	45.64	3.24	0.88	0.29	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	103.71	6.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	28.21	2.17	1.24	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	24.48	2.28	2.49	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	64.85	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	35.29	3.50	2.50	0.75	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	40.96	3.72	2.79	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.45	4.47	2.24	0.81	0.81
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.60	1.19	0.79	1.98	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	8.55	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	2.65	0.88	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	21.28	2.66	0.76	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	65.80	3.95	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.89	2.33	1.70	0.64	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	27.62	0.92	3.68	1.84	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	22.35	3.28	3.58	0.89	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	28.50	1.68	5.03	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	15.81	2.51	1.51	0.50	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.77	3.09	1.19	0.95	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	37.60	1.66	0.55	0.00	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.97	2.76	2.30	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	22.51	2.52	1.26	0.42	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.27	3.06	1.22	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.24	2.57	1.93	0.64	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.90	1.56	0.89	0.00	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	14.89	0.88	1.10	0.66	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	19.77	3.55	1.52	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	28.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	14.13	2.17	2.99	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.29	0.88	1.18	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	14.17	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.21	0.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.01	0.40	1.20	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	1.50	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	2.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	8.76	0.44	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	17.66	1.10	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	12.17	0.64	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.39	1.49	0.50	0.50	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	15.31	0.70	1.39	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	19.89	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.26	1.03	0.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	14.44	1.75	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.18	0.00	0.71	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.06	0.28	1.96	0.00	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	22.03	0.42	0.42	0.42	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	21.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.48	1.81	0.30	0.30	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.03	0.42	1.67	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	14.78	1.85	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	1.71	0.00	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	20.73	1.24	1.11	0.14	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	17.10	1.30	0.52	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	24.45	0.86	0.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.96	0.00	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	21.35	2.40	1.33	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	25.74	2.39	1.50	0.00	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	18.50	0.85	1.55	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	11.47	0.96	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	29.19	1.77	0.66	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	25.79	3.41	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	21.59	2.56	1.14	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	17.45	2.21	0.74	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	26.07	0.65	3.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	32.05	2.35	0.59	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	31.14	2.02	0.86	0.58	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	53.58	2.89	1.65	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	33.65	2.68	1.19	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	26.73	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	24.97	5.91	0.99	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	13.68	1.05	4.21	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	40.13	6.72	2.17	0.40	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	44.70	5.59	1.86	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	41.31	2.25	3.38	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	16.51	1.60	1.33	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	27.03	7.58	2.15	0.23	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.05	0.74	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	21.25	2.56	2.20	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	32.67	3.11	3.11	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	25.12	3.74	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	12.12	2.02	3.03	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	13.49	0.42	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	10.90	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	6.99	1.91	0.64	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	8.10	0.81	1.62	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	3.02	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	17.13	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	9.79	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	22.19	2.37	3.23	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	24.04	2.61	6.79	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.68	2.00	1.33	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	11.69	0.83	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	50.01	1.33	2.66	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	124.48	0.00	1.60	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	8.16	2.04	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	172.74	9.19	5.51	7.35	3.68
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.65	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	20.45	1.86	0.93	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	13.51	0.27	0.27	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.90	1.26	1.89	0.21	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	334.04	33.40	22.27	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	1.99	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	29.50	1.08	0.81	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	11.56	0.68	0.45	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	15.19	0.65	0.49	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.26	0.55	1.09	1.28	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	14.85	2.12	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	11.41	0.60	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	63.67	1.97	3.61	0.98	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	10.90	1.14	1.95	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	52.21	1.23	2.82	0.71	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	11.95	0.00	1.41	0.00	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.39	0.92	2.30	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	12.85	0.96	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	46.56	1.38	2.41	1.38	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	235.15	10.11	7.59	2.53	5.06
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	41.88	0.67	1.78	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	17.36	1.69	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	25.63	2.14	2.37	0.24	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.45	1.72	1.29	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	478.47	27.08	18.06	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	14.33	0.67	1.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	33.81	0.90	3.16	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	10.32	0.79	1.59	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	0.93	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.38	0.76	0.38	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	13.69	0.98	1.30	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.77	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	48.85	2.71	0.90	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	11.46	0.88	1.76	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	15.96	1.99	1.33	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	13.39	0.00	0.99	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	8.42	0.77	1.91	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	37.50	0.00	0.91	0.60	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	37.35	2.21	1.33	1.11	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.88	1.36	2.03	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	275.91	15.33	20.44	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.29	1.22	1.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	13.85	1.26	0.63	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	11.50	0.91	1.21	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	0.00	1.58	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	47.61	3.40	7.94	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	257.95	20.23	5.06	15.17	10.12
Myoblast, donor1	11241-116D8	23.23	3.23	2.61	0.37	0.62
Myoblast, donor2	11322-117D8	30.11	3.07	1.34	0.38	0.19
Myoblast, donor3	11398-118D3	33.80	3.03	0.84	0.17	0.67
NK T cell leukemia cell line:KHYG-1	10777-110G3	39.69	5.98	3.21	0.58	0.44
Natural Killer Cells, donor1	11230-116C6	140.84	15.68	10.15	26.45	0.62
Natural Killer Cells, donor2	11311-117C6	108.56	5.43	8.14	23.82	0.00
Natural Killer Cells, donor3	11387-118C1	101.60	7.73	5.89	22.27	0.37
Neural stem cells, donor1	11275-116H6	179.66	0.73	3.27	0.36	1.45
Neural stem cells, donor2	11352-117H2	179.08	0.00	3.85	0.00	1.93
Neurons, donor1	11494-119E9	79.65	0.00	1.14	1.14	0.00
Neurons, donor2	11574-120E8	86.74	0.66	0.44	0.22	1.10
Neurons, donor3	11655-122E8	61.66	0.00	0.00	2.47	0.82
Neutrophils, donor1	11233-116C9	26.91	7.42	6.50	2.78	0.93
Neutrophils, donor2	11314-117C9	14.49	11.60	8.70	2.90	0.00
Neutrophils, donor3	11390-118C4	34.21	12.83	5.50	6.72	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	64.71	2.02	4.99	0.71	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	15.30	0.00	0.98	0.98	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	18.85	0.80	2.41	0.20	0.60
Olfactory epithelial cells, donor1	11933-125I7	15.83	1.24	1.93	1.38	0.14
Olfactory epithelial cells, donor2	11934-125I8	24.03	2.32	1.45	3.76	0.29
Olfactory epithelial cells, donor3	11935-125I9	18.50	1.48	2.04	0.57	0.11
Olfactory epithelial cells, donor4	11936-126A1	30.87	2.92	2.05	0.39	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	20.46	2.41	1.81	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	13.83	2.34	0.85	0.00	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	2.29	1.14	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.24	0.62	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	2.93	0.00	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	47.76	2.11	2.11	0.00	1.40
Osteoblast, donor3	11426-118G4	15.46	0.53	0.89	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	45.32	3.79	2.78	0.51	0.42
Pericytes, donor1	11491-119E6	3.67	0.45	0.22	0.00	0.00
Pericytes, donor2	11571-120E5	3.40	0.00	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	3.66	0.00	0.41	0.00	0.20
Perineurial Cells, donor1	11499-119F5	28.14	2.15	2.26	0.11	0.11
Perineurial Cells, donor2	11579-120F4	32.39	2.12	2.21	0.46	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	125.90	14.98	13.07	6.06	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	79.83	9.30	9.06	2.45	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	65.48	10.22	10.48	6.60	0.65
Placental Epithelial Cells, donor1	11278-116H9	9.09	4.07	0.48	0.48	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	1.11	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.09	0.59	0.39	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	5.38	1.90	0.63	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	14.26	3.75	2.63	0.19	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.84	6.79	4.83	0.26	0.26
Preadipocyte - breast, donor2	11328-117E5	10.81	2.03	2.48	0.45	0.00
Preadipocyte - omental, donor1	11468-119C1	16.94	4.90	1.60	0.21	0.32
Preadipocyte - omental, donor2	11329-117E6	14.40	3.49	0.87	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	11.46	3.15	1.72	0.57	0.14
Preadipocyte - perirenal, donor1	11469-119C2	0.98	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	8.60	0.61	0.92	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	24.79	1.42	0.53	0.53	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	14.13	1.02	0.68	0.17	0.68
Preadipocyte - visceral, donor1	11280-116I2	41.82	1.77	1.40	0.19	1.12
Preadipocyte - visceral, donor2	11357-117H7	29.45	1.38	1.38	2.30	0.92
Preadipocyte - visceral, donor3	11429-118G7	19.44	1.46	1.15	0.63	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	32.13	3.02	2.26	0.75	0.60
Prostate Epithelial Cells, donor2	11331-117E8	8.67	1.76	1.76	0.54	0.14
Prostate Epithelial Cells, donor3	11404-118D9	4.59	7.72	4.35	0.73	0.12
Prostate Stromal Cells, donor1	11254-116F3	30.98	2.28	1.59	0.23	0.23
Prostate Stromal Cells, donor2	11332-117E9	29.76	1.97	1.79	0.54	0.54
Prostate Stromal Cells, donor3	11405-118E1	15.22	1.25	1.36	0.63	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.76	0.36	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	24.54	4.23	3.33	0.35	0.62
Renal Epithelial Cells, donor1	11517-119H5	4.06	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	3.56	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	29.75	2.43	3.07	0.42	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	7.49	0.68	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	6.74	1.08	0.54	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	32.41	2.44	1.55	2.00	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	1.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.28	0.66	0.44	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.64	1.25	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.05	0.00	0.00	0.28	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	6.71	1.34	0.81	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	4.64	1.69	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	6.36	0.19	0.77	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.26	3.63	1.30	0.52	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.38	0.85	0.28	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	11.32	0.00	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	44.16	4.27	4.52	1.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	59.47	17.11	7.75	0.94	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	58.96	7.15	1.79	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	42.93	6.05	2.20	2.75	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	113.69	1.74	2.32	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	55.26	1.30	0.91	0.65	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	31.38	2.68	0.79	0.50	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	41.94	1.90	1.23	0.33	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	36.22	2.60	1.49	0.99	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	31.70	2.10	1.17	1.17	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	29.35	1.16	1.62	1.16	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	27.52	2.19	0.82	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	31.62	1.51	1.51	0.61	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.49	1.79	1.08	0.54	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	20.37	2.01	1.00	0.72	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	24.36	2.15	0.43	0.75	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	29.87	1.99	1.55	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	29.63	1.53	0.38	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	33.17	2.05	1.12	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	58.25	3.38	1.32	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	28.53	1.73	0.40	0.13	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	32.71	1.75	1.07	0.58	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	31.70	1.34	0.76	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	23.92	1.39	0.96	0.32	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	28.31	2.80	1.96	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	38.79	2.22	1.03	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	23.52	2.19	1.09	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	27.35	1.10	1.59	1.23	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.70	2.28	1.75	0.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	20.05	0.47	0.47	0.47	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	29.17	0.40	1.19	1.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	28.06	1.64	1.40	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	17.83	0.62	1.66	0.41	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	37.38	2.21	0.88	3.10	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	29.45	1.25	1.88	0.42	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.34	1.35	0.94	0.54	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	33.21	1.87	1.19	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	37.02	1.54	1.74	0.19	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	21.66	2.75	1.03	0.17	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	36.08	3.29	1.51	0.14	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	34.97	1.64	1.48	1.15	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	25.39	1.87	1.36	0.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.37	2.66	0.89	0.59	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	36.25	1.60	1.60	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	35.26	1.94	1.11	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	24.76	2.38	0.24	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	47.97	3.02	1.21	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	24.67	1.04	0.66	0.28	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	45.42	1.75	3.49	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	44.12	1.81	2.42	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.74	1.84	0.12	0.24	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	138.42	5.97	3.93	0.73	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	38.94	1.83	3.04	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.02	1.81	0.30	0.90	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	36.87	1.36	1.58	0.23	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	52.42	2.40	1.20	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	39.55	2.01	0.83	0.35	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	33.08	2.35	1.71	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	66.11	2.40	2.40	0.60	0.00
Schwann Cells, donor1	11498-119F4	5.45	0.56	0.38	0.00	0.00
Schwann Cells, donor2	11578-120F3	30.62	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	22.35	1.31	0.88	0.88	0.00
Sebocyte, donor1	11220-116B5	7.67	1.64	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	5.06	1.84	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	2.06	0.62	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	21.54	4.97	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	19.77	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	36.42	0.97	2.55	0.18	0.79
Skeletal Muscle Cells, donor2	11358-117H8	6.51	1.45	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	16.72	0.00	0.00	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.81	1.89	1.57	0.31	0.63
Skeletal Muscle Cells, donor5	11455-119A6	29.58	2.38	1.64	0.74	0.30
Skeletal Muscle Cells, donor6	11459-119B1	34.01	1.39	1.85	1.23	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	52.92	3.65	5.42	0.50	0.38
Skeletal Muscle Satellite Cells, donor2	11321-117D7	41.09	2.00	3.28	0.57	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	42.26	1.69	1.29	0.89	0.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	42.80	1.77	1.43	0.25	1.01
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	1.45	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	8.12	0.00	0.14	0.14	0.28
Skin - palm, donor1	10286-104F7	134.31	8.06	16.12	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	4.90	0.86	0.86	0.58	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	75.25	10.63	7.36	3.27	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.84	0.91	0.91	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	20.30	7.78	3.61	0.97	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	22.36	4.08	3.94	0.56	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	78.23	11.21	5.29	0.42	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	14.09	7.42	5.32	0.22	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	5.55	0.62	0.93	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	16.45	2.22	2.22	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	21.16	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	11.71	0.88	0.44	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	4.73	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.09	1.55	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	23.02	0.00	1.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	7.98	0.93	0.80	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	19.51	2.22	2.66	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	7.81	2.18	1.66	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	35.49	2.93	3.58	0.65	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	35.14	3.25	2.36	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	13.52	1.85	2.14	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	2.28	0.16	0.16	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	33.49	2.13	2.74	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	14.65	1.26	1.52	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.29	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	29.35	2.06	2.51	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	17.43	2.37	1.51	0.65	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	22.15	2.41	1.57	0.42	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	7.58	0.62	0.31	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	6.28	0.30	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.07	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	46.18	2.12	2.43	0.55	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	18.52	2.11	1.51	0.00	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	21.16	2.05	1.14	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	4.23	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	44.24	3.44	1.85	0.26	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	43.01	1.73	1.07	0.13	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.53	0.88	1.63	0.63	0.38
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.58	2.03	1.52	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.15	1.21	0.45	0.15	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.75	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	14.21	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	11.16	0.47	0.93	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	10.60	0.50	0.50	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.64	0.94	0.31	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.77	0.59	0.59	0.29	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	56.40	3.58	3.25	0.08	1.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	0.47	1.87	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	4.46	1.30	0.29	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	13.77	1.27	0.76	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.64	0.19	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	38.43	2.66	1.68	0.70	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	18.60	1.34	1.68	0.08	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	6.85	0.49	0.98	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	18.12	1.10	0.22	0.00	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	25.75	0.88	2.63	0.00	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	28.57	1.17	2.72	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	17.72	1.32	0.00	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	26.41	1.86	1.12	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.20	2.16	1.80	1.80	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	18.74	3.12	1.99	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	34.66	4.33	1.18	1.18	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	23.11	2.29	1.27	2.03	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	27.95	2.40	1.60	2.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	18.81	2.93	1.25	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	27.04	1.83	0.92	0.92	0.46
Synoviocyte, donor1	11291-117A4	25.75	2.86	1.85	0.34	0.50
Synoviocyte, donor2	11368-117I9	13.07	1.34	1.01	0.67	0.17
Synoviocyte, donor3	11440-118H9	18.54	3.13	1.79	0.67	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	9.29	0.71	0.71	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	16.21	0.46	0.69	0.00	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	9.39	2.29	1.58	0.00	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	3.87	1.55	0.77	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	0.57	1.15	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	52.78	18.21	7.38	0.62	1.23
Urethra, donor2	10319-105A4	79.13	3.60	14.39	0.00	0.00
Urothelial Cells, donor1	11520-119H8	0.27	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.60	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	1.38	1.38	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	13.37	5.57	2.01	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	50.72	27.58	4.45	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	55.75	41.46	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	26.01	12.32	2.05	2.05	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	71.28	17.91	8.95	0.69	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	56.94	20.34	5.23	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	48.94	15.62	4.16	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	54.15	17.44	4.59	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	31.95	15.52	7.30	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	52.68	1.23	1.73	0.86	0.62
Wilms' tumor cell line:HFWT	10597-108E3	74.80	3.52	4.40	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	14.52	3.63	2.51	0.28	0.28
achilles tendon, donor2	10292-104G4	49.60	6.20	4.13	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	73.68	4.59	3.57	1.53	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	84.74	2.32	1.16	1.16	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	187.20	4.27	1.54	0.59	1.78
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	122.45	1.36	1.90	1.36	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	45.54	1.41	0.28	1.97	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	60.48	3.60	4.02	1.69	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	60.70	6.53	5.17	2.45	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	88.57	3.53	1.76	2.20	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	82.90	1.63	1.63	2.86	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	159.59	20.19	7.77	10.10	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	25.02	2.76	2.02	1.29	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	214.53	3.90	7.80	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	75.52	2.09	1.16	1.63	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	98.64	8.80	5.44	3.11	1.81
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	112.81	12.86	9.94	7.60	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	95.74	8.83	12.08	0.93	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	48.12	9.87	3.70	1.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	75.82	12.89	6.14	2.15	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	134.41	17.50	8.53	2.13	2.99
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	144.67	26.39	4.85	1.82	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	165.12	26.96	6.02	0.72	5.78
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	22.94	14.70	6.01	1.34	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	91.06	9.01	9.67	1.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	299.17	7.43	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	90.40	7.16	4.14	0.75	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	157.88	4.80	5.23	6.54	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	142.46	13.12	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	54.64	17.19	9.18	0.94	1.18
adipose tissue, adult, pool1	10010-101C1	60.03	14.27	8.07	0.78	0.78
adipose, donor1	10184-103D4	319.59	0.59	0.59	8.80	1.17
adipose, donor2	10185-103D5	64.88	0.41	0.00	0.41	0.41
adipose, donor3	10186-103D6	82.78	0.54	0.27	0.82	1.09
adipose, donor4	10187-103D7	106.61	1.73	2.60	1.73	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	119.31	3.95	5.37	0.63	0.95
adrenal gland, adult, pool1	10081-102A9	14.55	3.64	7.28	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	40.96	10.41	6.94	0.67	1.07
alveolar cell carcinoma cell line:SW 1573	10708-109H6	25.01	3.57	1.43	0.00	1.43
amniotic membrane cells, donor1	12235-129G3	17.62	12.29	9.04	0.46	1.16
amniotic membrane cells, donor2	12236-129G4	22.31	4.06	6.42	0.34	1.01
amniotic membrane cells, donor3	12237-129G5	14.14	16.79	10.90	1.18	0.88
amygdala - adult, donor10196	10167-103B5	123.32	2.37	3.56	1.19	2.37
amygdala, adult, donor10252	10151-102I7	147.01	6.89	4.26	0.81	1.22
amygdala, newborn, donor10223	10360-105E9	90.70	2.58	1.29	1.61	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	30.43	2.42	2.93	0.13	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	40.59	6.84	3.53	1.76	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	144.97	1.00	2.67	0.33	1.00
aorta, adult, pool1	10052-101G7	36.87	4.90	3.73	1.77	0.20
appendix, adult	10189-103D9	135.84	9.31	13.97	1.55	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	108.34	5.50	7.22	1.03	1.38
artery, adult	10190-103E1	86.96	12.23	9.51	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	83.88	4.35	2.75	0.87	0.29
b cell line:RPMI1788	10427-106D4	93.68	5.35	3.12	0.59	1.93
basal cell carcinoma cell line:TE 354.T	10702-109G9	15.26	3.05	2.50	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	42.67	8.04	6.95	0.50	0.99
bile duct carcinoma cell line:TFK-1	10496-107C1	16.40	9.54	4.69	0.50	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	82.77	12.86	10.07	3.91	1.12
bladder, adult, pool1	10011-101C2	89.09	15.97	9.56	0.65	0.54
blood, adult, pool1	10053-101G8	8.86	4.43	2.21	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	58.23	4.28	7.71	0.00	0.86
bone marrow, adult	10192-103E3	68.16	14.17	6.07	2.70	0.67
brain, adult, donor1	10084-102B3	48.18	1.03	1.03	1.03	3.08
brain, adult, pool1	10012-101C3	119.93	3.90	3.01	0.78	1.89
brain, fetal, pool1	10085-102B4	88.16	0.00	2.67	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	29.40	6.94	10.90	0.33	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	25.96	7.24	7.49	0.12	0.37
breast, adult, donor1	10080-102A8	20.83	6.94	3.16	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	13.72	5.84	1.91	0.64	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	21.03	3.40	2.16	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	28.55	2.99	2.30	1.38	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	14.04	4.84	1.94	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	54.07	5.17	3.76	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	39.81	12.80	11.48	0.44	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	70.98	0.32	0.32	0.95	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	144.27	1.33	2.40	3.73	1.33
caudate nucleus - adult, donor10196	10177-103C6	147.37	5.76	2.30	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	156.78	4.52	2.18	3.18	1.67
caudate nucleus, adult, donor10258	10379-105H1	116.91	1.53	0.76	1.53	4.58
caudate nucleus, newborn, donor10223	10354-105E3	122.69	2.20	0.37	1.10	1.10
cerebellum - adult, donor10196	10173-103C2	198.10	2.91	0.00	0.00	5.83
cerebellum, adult, donor10252	10166-103B4	204.12	20.50	10.03	3.20	1.49
cerebellum, adult, pool1	10083-102B2	78.99	4.83	5.17	1.38	1.03
cerebellum, newborn, donor10223	10357-105E6	283.13	7.47	5.81	3.32	5.81
cerebral meninges, adult	10188-103D8	165.40	2.02	2.52	2.02	2.27
cerebrospinal fluid, donor2	10294-104G6	65.05	3.65	2.19	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	32.78	6.33	6.33	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	36.13	4.14	4.97	0.00	0.33
cervix, adult, pool1	10013-101C4	123.26	9.03	7.56	1.05	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	35.53	4.60	1.53	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	37.88	10.45	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	28.33	10.56	7.46	0.99	0.75
choriocarcinoma cell line:SCH	10785-110H2	23.16	4.19	3.57	0.49	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	12.33	4.27	5.93	0.00	0.24
chorionic membrane cells, donor1	12238-129G6	16.53	9.40	4.56	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	21.87	3.78	2.88	0.50	0.40
chorionic membrane cells, donor3	12240-129G8	14.29	15.39	11.54	1.65	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	63.62	5.05	2.02	6.06	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	121.02	10.37	5.57	9.99	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	140.65	8.87	5.49	2.75	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	58.55	11.04	6.68	0.77	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	79.09	10.88	5.32	2.42	1.45
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	71.87	8.55	4.48	1.22	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	115.13	10.31	3.53	0.59	2.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	319.01	13.81	8.86	1.30	1.56
clear cell carcinoma cell line:JHOC-5	10638-108I8	64.00	5.49	5.03	3.89	0.23
clear cell carcinoma cell line:TEN	10636-108I6	28.11	6.07	6.42	0.17	0.35
colon carcinoma cell line:CACO-2	10513-107D9	39.72	3.11	3.29	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	79.06	2.66	3.04	0.38	0.76
colon, adult, donor1	10082-102B1	26.18	5.95	3.57	0.00	0.00
colon, adult, pool1	10014-101C5	57.93	16.80	7.52	0.35	0.82
colon, fetal, donor1	10070-101I7	56.85	5.56	6.18	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	1251.30	18.33	13.75	4.58	9.17
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	169.12	5.10	3.40	1.27	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	109.73	2.57	1.81	1.06	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	137.20	1.97	3.24	0.99	2.26
corpus callosum, adult, pool1	10042-101F6	128.81	6.41	3.98	0.44	1.44
cruciate ligament, donor2	10295-104G7	63.22	4.05	6.48	0.00	1.62
diaphragm, fetal, donor1	10069-101I6	74.64	9.63	6.42	0.00	0.00
diencephalon, adult	10193-103E4	110.87	3.84	1.20	1.68	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	59.70	4.59	3.21	2.76	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	53.60	12.57	8.46	0.26	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	40.68	1.93	5.78	0.00	0.24
ductus deferens, adult	10196-103E7	80.73	12.46	15.95	2.99	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	51.85	7.20	2.88	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	99.31	9.56	18.39	8.83	0.74
dura mater, adult, donor1	10041-101F5	94.81	9.99	6.44	0.50	1.82
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	106.59	2.89	1.11	0.44	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	70.93	1.72	1.00	0.14	1.00
embryonic pancreas cell line:1B2C6	10604-108F1	37.61	7.40	1.85	1.23	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	24.22	1.51	2.12	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	47.55	3.40	6.48	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	69.61	2.63	2.63	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	58.99	2.01	1.68	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	57.09	3.62	4.71	0.91	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	24.28	4.50	3.38	1.45	0.48
epidermoid carcinoma cell line:A431	10426-106D3	34.79	5.11	2.45	0.33	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	39.70	6.49	6.38	0.22	0.44
epididymis, adult	10197-103E8	114.91	8.16	6.91	1.26	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	90.83	3.55	1.06	0.71	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	36.57	5.11	1.57	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	32.11	12.06	5.24	1.18	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	40.25	12.70	6.69	1.48	0.98
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	33.83	11.09	4.26	2.02	0.22
esophagus, adult, pool1	10015-101C6	38.33	15.18	8.71	1.17	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	178.71	4.26	6.01	0.63	2.00
eye - muscle inferior rectus, donor1	10272-104E2	130.39	4.83	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	69.44	4.21	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	110.13	8.93	5.95	0.00	2.98
eye - muscle superior, donor2	10297-104G9	119.24	4.59	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	132.62	2.91	1.46	1.46	1.46
eye, fetal, donor1	10054-101G9	75.76	4.07	3.81	3.81	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	14.10	0.51	0.64	0.38	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	52.23	2.61	2.14	0.47	1.19
frontal lobe, adult, pool1	10040-101F4	156.97	5.44	3.00	0.38	3.66
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	51.34	6.91	5.10	0.30	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	29.26	3.29	5.03	0.18	0.09
gall bladder, adult	10198-103E9	58.67	7.48	6.28	0.24	0.72
gamma delta positive T cells, donor1	11937-126A2	86.97	7.52	7.52	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	78.43	8.22	9.71	4.48	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	31.05	3.59	0.84	0.42	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	23.60	8.70	6.77	0.58	0.39
gastric cancer cell line:AZ521	10549-107H9	120.34	3.61	1.80	0.16	1.15
gastric cancer cell line:GSS	10560-108A2	49.42	12.81	5.49	2.75	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	170.20	5.71	6.63	6.40	1.60
giant cell carcinoma cell line:LU65	10487-107B1	13.08	6.88	4.13	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	39.75	2.10	2.38	0.00	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.71	3.49	2.00	0.50	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	59.21	10.98	5.49	0.74	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	61.65	9.55	4.77	0.28	1.40
glioblastoma cell line:T98G	10485-107A8	58.17	3.97	4.86	0.55	0.88
glioma cell line:GI-1	10413-106B8	68.24	10.54	7.32	0.29	1.76
globus pallidus - adult, donor10196	10175-103C4	123.91	3.64	2.19	1.46	1.46
globus pallidus, adult, donor10252	10161-103A8	153.54	13.67	3.66	3.17	0.98
globus pallidus, adult, donor10258	10367-105F7	132.81	2.74	6.85	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	76.74	5.33	1.60	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	1646.93	19.58	26.92	7.34	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	10.93	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	33.28	2.88	2.56	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	49.58	3.21	0.92	2.30	0.46
hIPS +CCl2, biol_rep2	14384-156C1	60.82	1.37	1.83	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	51.53	0.64	3.22	0.64	0.00
hIPS, biol_rep1	14380-156B6	34.49	2.87	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	43.21	1.37	2.06	1.37	0.00
hIPS, biol_rep3	14382-156B8	131.31	5.52	3.31	4.41	1.10
hairy cell leukemia cell line:Mo	10712-109I1	47.70	2.01	0.86	2.59	1.72
heart - mitral valve, adult	10205-103F7	89.09	6.28	5.38	0.90	0.90
heart - pulmonic valve, adult	10206-103F8	98.58	16.73	11.50	0.52	0.78
heart - tricuspid valve, adult	10207-103F9	62.45	6.66	5.83	1.67	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	33.67	6.12	2.04	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	33.21	10.65	5.11	1.70	0.43
heart, adult, pool1	10016-101C7	66.46	17.71	11.50	0.46	1.15
heart, fetal, pool1	10046-101G1	146.94	8.52	7.29	0.51	1.23
hepatic mesenchymal tumor cell line:LI90	10778-110G4	16.97	2.47	4.01	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	90.38	2.38	15.46	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	110.72	7.85	1.66	1.99	1.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	111.18	8.50	3.03	2.67	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	126.42	12.13	2.93	2.22	1.62
hepatoma cell line:Li-7	10484-107A7	106.21	13.01	6.45	1.89	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	61.71	3.72	3.12	0.70	0.30
hippocampus - adult, donor10196	10169-103B7	153.31	0.00	1.89	2.84	0.95
hippocampus, adult, donor10252	10153-102I9	140.62	10.41	3.06	3.06	0.82
hippocampus, adult, donor10258	10374-105G5	118.01	3.49	3.49	1.49	1.49
hippocampus, newborn, donor10223	10363-105F3	88.47	1.41	0.35	1.06	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	100.71	4.88	6.10	5.49	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	45.16	1.37	3.73	1.18	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	65.76	1.78	4.06	1.52	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	69.92	1.13	0.00	1.13	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	81.08	0.77	1.03	10.33	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	97.18	0.76	1.14	1.52	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	136.63	0.00	0.29	3.50	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	122.58	0.43	0.86	2.15	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	126.79	0.42	1.25	1.67	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	131.66	0.24	0.47	0.95	2.60
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	91.93	0.16	0.48	2.57	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	126.58	0.00	0.67	2.02	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.18	1.10	3.60	1.10	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	52.08	1.97	3.93	3.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	74.18	1.75	4.36	3.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	103.28	1.34	0.38	1.72	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	82.85	0.00	0.44	0.87	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	160.42	0.50	0.50	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	74.23	0.75	0.19	1.13	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	91.85	0.00	0.45	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	91.78	0.63	0.00	1.57	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	69.57	0.16	0.16	0.65	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	68.51	0.00	0.58	1.16	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	81.31	0.60	0.30	1.49	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	43.05	0.92	2.59	1.85	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	33.09	2.57	3.71	1.14	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	65.33	0.82	4.49	2.86	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	84.85	0.35	1.41	7.39	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	63.98	0.32	0.00	0.95	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	79.29	0.61	0.61	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	70.85	0.52	0.00	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	84.35	0.00	0.00	2.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	112.36	0.77	0.51	0.51	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	74.39	0.00	0.51	4.86	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	102.98	0.00	1.51	4.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	85.02	0.00	0.34	0.67	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	38.88	0.97	2.66	0.24	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	56.15	3.57	4.01	0.89	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	44.39	1.95	4.39	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	81.91	0.61	0.61	1.83	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	784.03	6.51	0.00	26.03	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	124.77	0.99	1.99	1.65	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	102.89	0.00	0.00	2.19	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	90.47	0.36	0.72	0.72	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	105.69	0.00	0.36	1.42	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	70.41	0.00	0.00	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	137.73	0.27	0.54	0.81	1.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	70.31	0.27	0.27	0.54	0.81
immature langerhans cells, donor1	11904-125F5	48.43	11.62	3.15	2.18	0.73
immature langerhans cells, donor2	11905-125F6	27.72	7.13	3.17	1.58	0.00
insula, adult, pool1	10039-101F3	118.58	2.18	2.08	0.19	2.74
keratoacanthoma cell line:HKA-1	10791-110H8	8.78	1.63	0.98	0.00	0.00
kidney, adult, pool1	10017-101C8	64.38	8.21	5.01	1.10	0.80
kidney, fetal, pool1	10045-101F9	69.96	3.96	1.98	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	100.98	3.41	2.13	0.14	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.10	1.52	2.49	0.69	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	61.29	7.52	7.16	0.37	0.37
left atrium, adult, donor1	10079-102A7	29.42	4.36	1.09	1.63	0.54
left ventricle, adult, donor1	10078-102A6	35.40	9.61	4.05	1.52	1.01
leiomyoblastoma cell line:G-402	10721-110A1	48.70	1.09	2.46	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	10.06	1.44	1.44	1.08	0.72
leiomyoma cell line:15242A	10570-108B3	3.26	1.63	0.54	0.00	0.00
leiomyoma cell line:15425	10571-108B4	16.03	0.24	1.21	1.46	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	71.10	5.23	2.09	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	110.38	4.60	5.31	1.06	0.94
liposarcoma cell line:KMLS-1	10782-110G8	23.12	2.81	3.44	0.16	0.16
liposarcoma cell line:SW 872	10726-110A6	52.03	2.07	1.46	0.97	0.37
liver, adult, pool1	10018-101C9	45.70	17.18	3.57	0.32	1.30
liver, fetal, pool1	10086-102B5	32.92	0.94	0.94	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	119.72	3.94	3.35	1.17	0.73
locus coeruleus, adult, donor10252	10165-103B3	105.38	8.30	2.95	2.95	0.92
locus coeruleus, adult, donor10258	10375-105G6	64.89	2.82	2.54	2.26	1.41
locus coeruleus, newborn, donor10223	10362-105F2	131.65	7.99	2.10	1.68	1.68
lung adenocarcinoma cell line:A549	10499-107C4	52.87	9.27	6.92	0.42	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	24.13	4.83	6.89	0.00	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	40.73	2.24	2.24	0.40	0.13
lung, adult, pool1	10019-101D1	67.69	13.94	6.50	0.35	1.18
lung, fetal, donor1	10068-101I5	297.11	18.84	7.99	1.14	3.14
lung, right lower lobe, adult, donor1	10075-102A3	57.28	5.96	6.42	0.46	0.46
lymph node, adult, donor1	10077-102A5	27.46	2.37	5.21	3.31	0.00
lymphangiectasia cell line:DS-1	10727-110A7	25.42	3.73	6.14	0.44	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	48.15	2.72	1.51	0.60	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	26.33	5.10	1.70	0.85	0.85
mature adipocyte, donor1	12231-129F8	99.45	20.87	4.44	0.00	1.33
mature adipocyte, donor2	12232-129F9	82.39	17.64	4.77	0.62	1.04
mature adipocyte, donor3	12233-129G1	65.43	22.28	6.87	0.24	0.71
mature adipocyte, donor4	12234-129G2	111.87	25.01	8.69	1.32	2.37
maxillary sinus tumor cell line:HSQ-89	10414-106B9	59.80	17.15	16.20	0.00	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	122.96	1.13	4.51	1.13	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	132.23	8.83	4.97	2.57	2.39
medial frontal gyrus, adult, donor10258	10368-105F8	121.99	1.91	2.22	3.18	3.18
medial frontal gyrus, newborn, donor10223	10352-105E1	166.33	4.26	1.71	1.71	2.56
medial temporal gyrus - adult, donor10196	10183-103D3	135.68	3.21	2.03	13.84	2.87
medial temporal gyrus, adult, donor10252	10156-103A3	130.09	9.13	2.76	2.12	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	77.05	0.00	0.00	5.78	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	832.51	14.35	0.00	57.41	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	79.68	1.44	1.44	0.72	1.44
medulla oblongata - adult, donor10196	10174-103C3	105.13	0.65	1.30	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	128.95	13.00	4.95	2.01	0.62
medulla oblongata, adult, pool1	10038-101F2	96.73	4.00	2.94	0.08	1.31
medulla oblongata, newborn, donor10223	10361-105F1	94.43	4.17	2.78	1.04	1.04
medulloblastoma cell line:D283 Med	10838-111E1	117.13	4.65	1.99	2.21	1.55
medulloblastoma cell line:ONS-76	10759-110E3	55.63	2.32	4.04	0.24	0.37
melanoma cell line:COLO 679	10514-107E1	78.49	4.31	2.59	0.86	0.43
melanoma cell line:G-361	10465-106H6	20.90	1.90	0.81	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	20.26	3.08	0.72	0.54	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	118.08	0.88	1.76	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	110.43	1.04	0.52	0.78	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	22.40	1.99	1.69	0.92	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.18	1.27	2.00	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.39	2.90	0.83	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.37	2.95	1.26	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	20.60	1.35	0.96	0.19	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	26.37	2.78	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	14.59	4.98	1.03	0.69	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	21.74	1.50	1.38	0.58	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	24.01	1.19	0.53	0.80	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	25.79	2.97	2.03	0.68	0.54
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	23.90	2.28	1.28	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	21.08	4.94	1.65	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	28.23	2.21	0.83	0.69	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.07	0.70	1.05	1.40	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.45	1.43	1.22	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	18.33	3.95	1.44	0.36	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.86	1.97	1.34	0.31	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	8.66	2.05	0.68	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	29.37	4.20	3.78	1.26	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	26.45	2.09	1.34	0.45	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.86	2.10	2.19	0.18	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	19.51	5.52	1.84	0.74	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	20.03	1.14	1.72	0.29	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	39.58	3.37	1.68	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	12.79	0.46	1.37	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	18.42	1.28	2.30	0.77	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	19.89	2.88	2.09	0.52	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.40	0.92	3.70	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.53	1.18	2.59	0.47	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	16.25	1.35	2.03	0.68	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.47	2.75	2.36	0.79	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	19.93	1.39	2.78	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	24.80	0.58	3.46	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	18.07	1.34	2.45	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	16.34	1.44	2.40	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	44.73	2.20	8.07	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.78	1.68	0.34	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.70	2.05	1.23	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	17.18	0.86	0.86	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	26.31	2.60	2.92	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	1.45	1.45	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	19.72	1.60	0.53	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.90	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	16.71	1.55	2.33	0.39	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	2.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	17.88	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	23.72	0.59	2.96	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	0.00	2.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	22.17	1.27	2.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	20.69	2.41	2.07	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	0.00	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	9.78	1.63	1.22	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	0.00	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.97	0.00	2.36	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.60	1.25	1.25	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	16.04	1.34	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	17.74	2.37	3.55	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	0.69	1.38	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.36	1.98	0.49	0.99	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	13.46	0.00	1.12	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.90	1.27	0.64	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	6.04	1.21	0.81	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	0.00	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	8.50	4.86	1.21	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	0.00	4.52	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.83	4.94	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	13.49	1.59	0.40	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	11.68	1.62	0.00	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	21.39	2.04	0.00	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	87.43	6.96	3.09	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	51.74	8.98	1.65	0.47	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	40.08	6.95	2.78	0.70	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	29.92	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	43.05	4.11	1.54	1.03	0.72
mesothelioma cell line:Mero-25	10850-111F4	34.72	1.82	0.68	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	16.14	3.91	4.16	1.47	0.00
mesothelioma cell line:Mero-48a	10852-111F6	14.39	3.10	2.88	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	50.46	1.84	1.05	4.47	0.00
mesothelioma cell line:Mero-83	10854-111F8	25.70	1.02	1.02	0.85	0.51
mesothelioma cell line:Mero-84	10855-111F9	14.66	1.26	1.01	0.00	0.51
mesothelioma cell line:Mero-95	10856-111G1	11.39	2.69	1.24	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	14.58	2.98	0.50	0.50	0.33
mesothelioma cell line:NCI-H226	10846-111E9	30.23	2.35	0.54	0.54	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	24.60	3.76	1.37	0.51	1.02
mesothelioma cell line:NCI-H28	10845-111E8	30.28	3.31	3.05	1.27	0.00
mesothelioma cell line:No36	10857-111G2	12.72	2.28	0.65	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	8.94	5.42	1.35	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	22.84	3.84	5.76	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	18.32	5.62	5.13	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	30.51	5.74	6.28	0.18	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	47.67	6.86	5.22	2.94	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	17.38	0.85	0.85	1.06	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	15.20	6.91	5.53	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	31.02	1.90	1.14	1.33	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	89.07	12.20	10.72	0.74	1.11
myeloma cell line:PCM6	10474-106I6	32.02	8.10	8.50	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	63.92	3.04	2.54	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.42	5.49	1.77	0.78	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.25	7.35	6.02	0.11	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	9.05	11.69	6.18	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	23.18	5.52	4.97	1.10	1.10
neuroblastoma cell line:CHP-134	10508-107D4	161.04	1.38	1.38	0.23	1.38
neuroblastoma cell line:NB-1	10539-107G8	168.00	1.12	1.68	0.00	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	57.78	1.05	0.63	1.27	0.21
neuroblastoma cell line:NH-12	10555-107I6	188.59	1.12	1.86	3.91	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	115.05	0.47	1.19	3.32	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	138.27	1.90	1.27	3.96	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	38.64	0.60	1.61	0.81	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	244.13	4.45	8.90	0.00	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	20.49	3.73	0.80	0.00	0.53
neutrophil PMN, donor1	12133-128D9	342.12	59.50	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	28.41	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	478.95	3.38	2.71	3.04	3.38
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	66.44	7.20	8.01	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.72	1.28	1.92	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	24.96	1.58	1.31	1.05	0.00
nucleus accumbens, adult, pool1	10037-101F1	140.05	4.59	2.62	0.66	2.62
occipital cortex - adult, donor10196	10172-103C1	140.11	6.18	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	143.31	11.27	2.42	2.15	1.88
occipital cortex, newborn, donor10223	10355-105E4	85.53	1.09	1.82	0.73	1.46
occipital lobe, adult, donor1	10076-102A4	85.54	1.84	0.79	1.05	1.57
occipital lobe, fetal, donor1	10073-102A1	199.10	1.29	0.86	1.72	1.29
occipital pole, adult, pool1	10036-101E9	61.97	1.58	1.66	0.16	1.81
olfactory region, adult	10195-103E6	108.33	3.44	2.87	2.87	1.72
optic nerve, donor1	10277-104E7	198.10	8.00	14.01	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.36	7.18	4.33	0.11	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	35.58	1.10	1.92	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	31.83	2.20	2.88	2.54	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	32.00	2.66	2.77	1.50	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	35.28	2.65	3.82	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	180.33	8.41	9.34	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	79.10	7.00	6.15	2.76	0.21
ovary, adult, pool1	10020-101D2	113.64	6.03	6.20	0.44	1.22
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	24.75	2.93	1.83	0.00	0.37
pancreas, adult, donor1	10049-101G4	20.69	5.64	2.82	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	16.21	3.63	4.19	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	41.57	2.90	1.53	2.38	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.64	5.30	2.15	0.33	0.83
paracentral gyrus, adult, pool1	10035-101E8	106.17	3.20	1.83	0.46	1.74
parietal cortex, adult, donor10258	10373-105G4	138.73	2.20	0.73	1.47	1.47
parietal lobe - adult, donor10196	10171-103B9	100.63	4.70	3.76	2.82	2.82
parietal lobe, adult, donor10252	10157-103A4	130.55	8.55	2.85	1.43	2.28
parietal lobe, adult, pool1	10034-101E7	88.21	2.82	1.94	0.70	2.11
parietal lobe, fetal, donor1	10072-101I9	309.38	1.94	0.00	2.91	2.91
parietal lobe, newborn, donor10223	10356-105E5	97.20	2.24	0.75	0.00	0.00
parotid gland, adult	10199-103F1	23.43	12.33	11.10	0.62	0.00
penis, adult	10200-103F2	90.23	18.80	12.89	3.22	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	114.91	13.76	4.46	2.42	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.88	2.48	2.62	0.44	0.29
pineal gland - adult, donor10196	10179-103C8	147.71	3.23	2.58	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	207.27	12.44	4.15	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	112.25	6.90	6.27	0.63	3.14
pituitary gland - adult, donor10196	10180-103C9	197.30	4.05	5.06	4.05	2.02
pituitary gland, adult, donor10252	10162-103A9	292.38	18.24	16.68	3.65	0.00
pituitary gland, adult, donor10258	10378-105G9	108.96	4.26	6.81	4.26	2.55
placenta, adult, pool1	10021-101D3	47.41	15.91	8.39	0.65	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	58.40	3.31	1.59	1.06	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	32.84	7.63	3.42	0.00	1.56
pons, adult, pool1	10033-101E6	118.86	7.49	4.30	0.69	2.93
postcentral gyrus, adult, pool1	10032-101E5	78.11	1.92	1.39	0.44	1.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	727.81	14.64	6.27	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	0.00	5.51	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	23.47	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	77.78	4.66	1.46	1.02	0.58
prostate cancer cell line:PC-3	10439-106E7	55.18	4.17	2.90	0.73	0.18
prostate, adult, pool1	10022-101D4	71.01	11.43	7.80	0.45	0.73
putamen, adult, donor10196	10176-103C5	229.45	3.54	3.07	2.36	1.89
putamen, adult, donor10252	10152-102I8	160.78	3.92	1.96	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	56.83	2.19	2.19	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	141.58	2.42	1.69	5.56	1.45
putamen, newborn, donor10223	10365-105F5	92.21	3.75	0.75	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	22.98	3.49	2.33	0.00	0.00
rectum, fetal, donor1	10067-101I4	118.23	2.78	2.78	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	16.11	3.60	1.48	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	19.47	5.80	0.83	0.41	0.00
retina, adult, pool1	10030-101E3	84.79	7.85	4.37	0.20	0.70
retinoblastoma cell line:Y79	10475-106I7	152.24	1.30	1.30	1.30	3.12
rhabdomyosarcoma cell line:KYM-1	10787-110H4	114.34	1.48	1.23	0.98	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	293.29	1.12	2.81	0.00	1.97
sacrococcigeal teratoma cell line:HTST	10695-109G2	93.22	6.06	3.79	0.00	1.52
salivary acinar cells, donor1	11771-123I7	26.06	3.88	3.72	0.65	0.81
salivary acinar cells, donor2	11772-123I8	28.23	4.68	3.17	1.10	0.14
salivary acinar cells, donor3	11773-123I9	38.40	14.57	5.96	0.00	0.00
salivary gland, adult, pool1	10093-102C3	32.60	9.15	6.86	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	64.58	4.38	2.95	0.76	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	62.54	4.11	2.00	0.82	0.82
seminal vesicle, adult	10201-103F3	97.88	9.52	15.87	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.22	5.59	4.13	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	19.38	4.03	2.01	1.01	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	24.08	4.01	3.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	40.70	1.61	1.34	1.07	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	82.56	19.56	9.73	0.22	0.99
signet ring carcinoma cell line:NUGC-4	10483-107A6	37.93	16.26	5.29	1.29	0.77
skeletal muscle - soleus muscle, donor1	10282-104F3	112.07	9.93	3.55	2.84	0.71
skeletal muscle, adult, pool1	10023-101D5	120.30	25.55	6.84	0.60	2.28
skeletal muscle, fetal, donor1	10066-101I3	46.23	1.01	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	99.10	3.16	4.42	0.00	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	57.37	3.34	3.34	1.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	218.75	4.41	5.99	8.83	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	105.24	0.96	0.19	1.93	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	66.10	8.57	5.60	0.82	1.65
small cell lung carcinoma cell line:NCI-H82	10842-111E5	98.60	6.11	0.48	0.97	1.45
small cell lung carcinoma cell line:WA-hT	10562-108A4	38.79	1.74	1.74	0.22	0.22
small intestine, adult, pool1	10024-101D6	46.58	22.81	12.42	1.79	0.60
small intestine, fetal, donor1	10064-101I1	47.17	4.67	5.90	2.70	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	44.11	11.80	5.64	4.62	0.00
smooth muscle, adult, pool1	10048-101G3	85.03	9.56	8.79	2.07	1.29
somatostatinoma cell line:QGP-1	10781-110G7	11.79	9.38	9.38	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	124.11	2.98	1.84	3.90	1.84
spinal cord, adult, donor10252	10159-103A6	154.55	12.62	7.49	1.58	1.58
spinal cord, adult, donor10258	10369-105F9	177.10	3.46	2.77	6.23	0.00
spinal cord, fetal, donor1	10056-101H2	84.77	1.22	0.61	1.22	1.83
spinal cord, newborn, donor10223	10359-105E8	163.02	7.35	4.59	2.76	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	27.18	2.24	2.84	0.30	0.30
spleen, adult, pool1	10025-101D7	65.31	7.93	5.07	0.66	0.77
spleen, fetal, pool1	10044-101F8	53.71	5.96	1.99	0.79	0.56
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	83.84	11.08	3.52	1.45	1.14
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	25.82	4.94	1.14	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	40.54	3.84	4.19	1.40	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	21.11	3.91	2.74	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	41.76	2.03	4.28	0.45	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.98	2.12	0.42	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	29.19	3.81	0.42	0.85	0.85
stomach, fetal, donor1	10062-101H8	119.61	4.27	5.34	1.07	0.00
submaxillary gland, adult	10202-103F4	55.83	11.39	10.25	1.71	0.00
substantia nigra - adult, donor10196	10178-103C7	325.64	0.00	0.00	108.55	0.00
substantia nigra, adult, donor10252	10158-103A5	122.34	11.22	4.98	3.12	0.62
substantia nigra, adult, donor10258	10371-105G2	119.48	3.62	3.62	2.59	1.03
substantia nigra, newborn, donor10223	10358-105E7	81.96	2.12	2.12	2.12	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	63.28	3.90	2.98	0.23	1.60
temporal lobe, adult, pool1	10031-101E4	68.24	1.86	1.70	0.17	1.10
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	180.92	0.71	0.00	0.71	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	168.78	2.64	0.44	0.88	1.32
tenocyte, donor1	11763-123H8	23.74	2.44	1.40	1.75	0.70
tenocyte, donor2	11765-123I1	16.79	1.91	2.67	0.00	0.76
tenocyte, donor3	11768-123I4	16.68	1.85	1.85	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	60.34	2.04	2.55	0.85	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	39.15	0.92	0.77	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	53.00	1.39	2.79	0.93	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	41.77	3.94	3.94	0.25	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	57.10	7.94	13.24	1.13	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	71.98	8.72	6.00	0.98	1.20
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	60.26	8.14	2.61	5.54	0.65
testis, adult, pool1	10026-101D8	261.24	6.76	5.26	1.72	22.33
testis, adult, pool2	10096-102C6	298.62	4.96	5.41	17.14	26.61
thalamus - adult, donor10196	10168-103B6	123.65	12.14	3.31	3.31	2.21
thalamus, adult, donor10252	10154-103A1	151.59	11.56	4.84	3.13	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	67.74	10.78	1.54	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	52.70	2.96	2.80	1.81	0.49
thalamus, newborn, donor10223	10366-105F6	78.24	1.73	2.30	1.15	2.88
throat, adult	10209-103G2	71.41	15.98	5.49	2.25	0.75
throat, fetal, donor1	10061-101H7	112.74	3.66	7.62	3.05	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	63.20	0.40	2.19	0.60	0.40
thymus, adult, pool1	10027-101D9	183.32	5.17	4.67	2.39	1.99
thymus, fetal, pool1	10043-101F7	174.25	6.34	4.68	1.77	1.77
thyroid carcinoma cell line:KHM-5M	10776-110G2	31.25	8.78	7.45	0.80	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	37.02	4.47	2.37	0.42	0.00
thyroid, adult, pool1	10028-101E1	83.33	11.57	8.96	1.03	1.12
thyroid, fetal, donor1	10060-101H6	111.27	2.64	7.91	2.64	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	95.47	3.08	6.16	3.08	0.00
tongue, adult	10203-103F5	56.28	9.77	8.84	3.49	0.47
tongue, fetal, donor1	10059-101H5	57.14	5.52	5.12	1.18	0.00
tonsil, adult, pool1	10047-101G2	54.60	8.01	5.21	0.60	0.90
trachea, adult, pool1	10029-101E2	75.42	11.70	8.26	0.98	1.80
trachea, fetal, donor1	10058-101H4	86.17	5.00	5.00	1.92	1.54
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	33.66	1.06	2.83	0.71	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	79.74	2.23	4.36	0.41	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	65.34	8.93	9.24	0.78	0.78
tridermal teratoma cell line:HGRT	10694-109G1	150.30	1.90	9.51	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	29.37	3.05	2.37	0.17	0.25
umbilical cord, fetal, donor1	10057-101H3	54.25	4.17	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	104.25	4.95	4.27	0.51	1.02
uterus, fetal, donor1	10055-101H1	108.53	1.54	1.02	1.54	1.54
vagina, adult	10204-103F6	55.57	26.49	7.11	0.00	3.23
vein, adult	10191-103E2	65.32	7.01	5.26	2.41	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	50.47	1.87	1.07	0.80	0.00